NEW DRUGS IN THE TREATMENT OF TUBERCULOSIS

  • Greta Musteikienė
Keywords: multidrug-resistant tuberculosis, bedaquiline, delamanid, clofazimine, linezolid

Abstract

Despite the fact, that the incidence of tuberculosis in Lithuania is decreasing, incidence of multidrug-resistant tuberculosis remains unacceptably high. In recent years, there were new developments in the field of multidrug-resistant tuberculosis, including the apearance of new drugs, which are reviewed in this article.

Author Biography

Greta Musteikienė

Department of Pulmonology, Medical Academy, Lithuanian University of Health Sciences

How to Cite
1.
Musteikienė G. NEW DRUGS IN THE TREATMENT OF TUBERCULOSIS [Internet]. PIA 2016 Sep.;19(2):28-30.[cited 2024 Nov. 22 ] Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/248